Filing Details
- Accession Number:
- 0000905148-25-001466
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-05-06 16:15:27
- Reporting Period:
- 2025-05-02
- Filing Date:
- 2025-05-06
- Accepted Time:
- 2025-05-06 16:15:27
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 64803 | Cvs Health Corp | CVS | Retail-Drug Stores And Proprietary Stores (5912) | 050494040 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1228603 | Larry Robbins | 767 Fifth Avenue, 44Th Floor New York NY 10153 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2025-05-02 | 1,679,736 | $67.39 | 10,267,063 | No | 4 | S | Indirect | Held by Glenview Investment Funds |
| Common Stock | Disposition | 2025-05-02 | 222,556 | $68.38 | 10,044,507 | No | 4 | S | Indirect | Held by Glenview Investment Funds |
| Common Stock | Disposition | 2025-05-02 | 373,776 | $69.66 | 9,670,731 | No | 4 | S | Indirect | Held by Glenview Investment Funds |
| Common Stock | Disposition | 2025-05-05 | 1,226,933 | $67.37 | 8,443,798 | No | 4 | S | Indirect | Held by Glenview Investment Funds |
| Common Stock | Disposition | 2025-05-05 | 96,999 | $67.99 | 8,346,799 | No | 4 | S | Indirect | Held by Glenview Investment Funds |
| Common Stock | Disposition | 2025-05-06 | 150,000 | $66.67 | 8,196,799 | No | 4 | S | Indirect | Held by Glenview Investment Funds |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | Held by Glenview Investment Funds |
| No | 4 | S | Indirect | Held by Glenview Investment Funds |
| No | 4 | S | Indirect | Held by Glenview Investment Funds |
| No | 4 | S | Indirect | Held by Glenview Investment Funds |
| No | 4 | S | Indirect | Held by Glenview Investment Funds |
| No | 4 | S | Indirect | Held by Glenview Investment Funds |
Footnotes
- These shares of the Issuer's common stock (the "Shares") are held for the accounts of Glenview Capital Master Fund, Ltd., Glenview Offshore Opportunity Master Fund, Ltd. (the "GO Fund"), Glenview Healthcare Master Fund, L.P., and GCM Suggestivist I Master Fund, L.P. (collectively, the "Glenview Investment Funds").
- This price reflects the weighted average price for open-market sales of Shares on May 2, 2025 within a $1.00 range. The actual prices for these transactions range from $67.08 to $68.07, inclusive. The Reporting Person further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price.
- The Reporting Person disclaims beneficial ownership over any securities owned by the Glenview Investment Funds other than to the extent of any pecuniary interest he may have therein.
- The Glenview Investment Funds are the record holders of the Shares. The Reporting Person is the Founder, Portfolio Manager and CEO of Glenview Capital Management, LLC, which serves as investment manager to each of the Glenview Investment Funds. The Reporting Person shares voting and dispositive power over the Shares held by the Glenview Investment Funds and may be deemed to beneficially own such Shares.
- This price reflects the weighted average price for open-market sales of Shares on May 2, 2025 within a $1.00 range. The actual prices for these transactions range from $68.08 to $69.0764, inclusive. The Reporting Person further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price.
- This price reflects the weighted average price for open-market sales of Shares on May 2, 2025 within a $1.00 range. The actual prices for these transactions range from $69.0817 to $70.035, inclusive. The Reporting Person further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price.
- This price reflects the weighted average price for open-market sales of Shares on May 5, 2025 within a $1.00 range. The actual prices for these transactions range from $66.925 to $67.92, inclusive. The Reporting Person further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price.
- This price reflects the weighted average price for open-market sales of Shares on May 5, 2025 within a $1.00 range. The actual prices for these transactions range from $67.925 to $68.26, inclusive. The Reporting Person further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price.
- This price reflects the weighted average price for open-market sales of Shares on May 6, 2025 within a $1.00 range. The actual prices for these transactions range from $66.235 to $67.05, inclusive. The Reporting Person further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price.
Billionaire Hedge Funds
